Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$822K Buy
1,764
+127
+8% +$53.4K 0.01% 345
2026
Q1
$618K Buy
1,637
+43
+3% +$18.4K 0.01% 420
2025
Q4
$682K Sell
1,594
-103
-6% -$44.8K 0.01% 378
2025
Q3
$760K Sell
1,697
-93
-5% -$42.1K 0.01% 362
2025
Q2
$872K Buy
1,790
+145
+9% +$82.6K 0.01% 310
2025
Q1
$1.01M Buy
1,645
+101
+7% +$57.4K 0.01% 246
2024
Q4
$818K Sell
1,544
-331
-18% -$187K 0.01% 267
2024
Q3
$1.02M Buy
1,875
+200
+12% +$113K 0.01% 266
2024
Q2
$1.08M Buy
1,675
+46
+3% +$26.3K 0.01% 208
2024
Q1
$1.05M Buy
1,629
+85
+6% +$51.6K 0.01% 174
2023
Q4
$802K Buy
1,544
+16
+1% +$8.95K 0.01% 183
2023
Q3
$828K Buy
1,528
+42
+3% +$21.8K 0.01% 188
2023
Q2
$799K Sell
1,486
-92
-6% -$50.3K 0.01% 184
2023
Q1
$805K Buy
1,578
+30
+2% +$15.3K 0.01% 213
2022
Q4
$676K Buy
1,548
+38
+3% +$18.5K 0.01% 211
2022
Q3
$708K Buy
1,510
+13
+0.9% +$6.25K 0.01% 172
2022
Q2
$758K Buy
+1,497
New +$730K 0.01% 160

Other funds holding CHE

Blue Trust Inc's CHE Position: Q2 2026 in Review

Blue Trust Inc increased its Chemed (CHE) stake by 7.8% in Q2 2026, buying an estimated $53.4K and bringing the position to 1,764 shares worth $822K. The position accounts for 0.01% of the portfolio, ranked #345.

Blue Trust Inc first reported a position in CHE in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.08M in Q2 2024. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Blue Trust Inc held 1,764 shares of Chemed worth $822K as of Q2 2026.
  • Blue Trust Inc bought 127 Chemed shares in Q2 2026, an estimated $53.4K.
  • Chemed made up 0.01% of Blue Trust Inc's portfolio in Q2 2026, its #345 holding.
  • Blue Trust Inc first reported a position in Chemed in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Chemed position peaked at $1.08M in Q2 2024.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.